Four-Pronged attack on rare brain cancer
NCT ID NCT07198464
Summary
This study is testing a combination of four different treatments for a rare type of brain cancer called primary central nervous system lymphoma. The treatment includes a personalized immune cell therapy (CAR-T), a stem cell transplant, and two other drugs. The goal is to see if this combined approach is safe and effective at controlling the cancer in adults who have not responded well to initial treatment or whose cancer has returned.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.